Pravastatin Sodium + Cholestyramine Light Interaction
Moderateinteraction on record
Description
Concomitant administration decreases pravastatin AUC by 40-50%; clinically significant timing separation required.
Mechanism
Reduced bioavailability via binding or absorption interference
Source: NLP:pravastatin sodium